Donald R. Proctor
Directeur/Bestuurslid bij The Leukemia & Lymphoma Society, Inc.
Profiel
Donald R.
Proctor is currently a Director at The Leukemia & Lymphoma Society, Inc. Prior to this, he was a Senior Vice President at Cisco Systems, Inc. from 2012 to 2016.
He received his undergraduate degree from the University of California, Berkeley.
Actieve functies van Donald R. Proctor
| Bedrijven | Functie | Begin |
|---|---|---|
The Leukemia & Lymphoma Society, Inc.
 The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Donald R. Proctor
| Bedrijven | Functie | Einde |
|---|---|---|
| CISCO SYSTEMS, INC. | Corporate Officer/Principal | 01-10-2016 |
Opleiding van Donald R. Proctor
| University of California, Berkeley | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CISCO SYSTEMS, INC. | Electronic Technology |
| Bedrijven in privébezit | 1 |
|---|---|
The Leukemia & Lymphoma Society, Inc.
The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Commercial Services |
